Italia markets closed

BMY Jan 2026 35.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
2,0500-0,1000 (-4,65%)
Alla chiusura: 02:56PM EDT
Schermo intero
Chiusura precedente2,1500
Aperto2,0500
Denaro1,8600
Lettera2,1800
Prezzo d'esercizio35,00
Scadenza2026-01-16
Min-Max giorno2,0500 - 2,0500
Contratto - Min-MaxN/D
Volume2
Open Interest547
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri